Imperial College London

Prof. Diana Gorog

Faculty of MedicineNational Heart & Lung Institute

Honorary Senior Research Fellow



+44 (0)20 7034 8934d.gorog




Royal BromptonRoyal Brompton Campus





Consultant Cardiologist with a research interest in coronary thrombosis. 



Gue YX, Memtsas V, Kanji R, et al., 2024, Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study., Thromb Res, Vol:236, Pages:144-154

Leader JH, Kanji R, Gorog DA, 2024, Spontaneous reperfusion in STEMI: Its mechanisms and possible modulation., Kardiol Pol

RECOVERY Collaborative Group, 2024, Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial, The Lancet Child & Adolescent Health, Vol:8, ISSN:2352-4642, Pages:190-200

Byrne RA, Rossello X, Coughlan JJ, et al., 2024, 2023 ESC Guidelines for the management of acute coronary syndromes., Eur Heart J Acute Cardiovasc Care, Vol:13, Pages:55-161

Ding WY, Fawzy AM, Romiti GF, et al., 2024, Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry., J Thromb Thrombolysis, Vol:57, Pages:39-49

More Publications